MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

Search

Smith & Nephew PLC ADR

Cerrado

33.49 1.24

Resumen

Variación precio

24h

Actual

Mínimo

33.11

Máximo

33.89

Métricas clave

By Trading Economics

Ingresos

35M

331M

Ventas

203M

3.2B

P/B

Media del Sector

22.818

66.418

Rentabilidad por dividendo

2.43

Margen de beneficios

10.368

Empleados

16,988

EBITDA

133M

856M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+5.52% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

2.43%

2.36%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.3B

14B

Apertura anterior

32.25

Cierre anterior

33.49

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Smith & Nephew PLC ADR Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

10 abr 2026, 17:04 UTC

Principales Movimientos del Mercado

FDA Rejects Replimune's Melanoma Drug for a Second Time

11 abr 2026, 00:00 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Big Yachts, Big Bucks -- Barrons.com

10 abr 2026, 21:55 UTC

Adquisiciones, fusiones, absorciones

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 abr 2026, 21:01 UTC

Ganancias

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 abr 2026, 20:50 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

10 abr 2026, 20:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

10 abr 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

10 abr 2026, 20:31 UTC

Charlas de Mercado

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 abr 2026, 20:10 UTC

Adquisiciones, fusiones, absorciones

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 abr 2026, 19:15 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

10 abr 2026, 19:15 UTC

Charlas de Mercado

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 abr 2026, 19:08 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

10 abr 2026, 19:08 UTC

Charlas de Mercado

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 abr 2026, 18:38 UTC

Charlas de Mercado

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10 abr 2026, 18:25 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Precious Metals Finish With Weekly Gains -- Market Talk

10 abr 2026, 18:05 UTC

Charlas de Mercado

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10 abr 2026, 17:31 UTC

Charlas de Mercado
Noticias de Eventos Importantes

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10 abr 2026, 17:26 UTC

Ganancias

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10 abr 2026, 17:10 UTC

Charlas de Mercado

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10 abr 2026, 17:00 UTC

Noticias de Eventos Importantes

Construction Business Taking a Hit From Iran Conflict -- WSJ

10 abr 2026, 16:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

10 abr 2026, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

10 abr 2026, 16:12 UTC

Ganancias

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10 abr 2026, 16:11 UTC

Ganancias

Partners Group: Traditional Programs Contributed $3.3B

10 abr 2026, 16:10 UTC

Ganancias

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10 abr 2026, 16:10 UTC

Ganancias

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10 abr 2026, 16:10 UTC

Ganancias

Partners Group 1Q New Client Demand $8.3B

10 abr 2026, 16:09 UTC

Ganancias

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10 abr 2026, 15:54 UTC

Adquisiciones, fusiones, absorciones

Plenitude Completes Acquisition of Acea Energia

10 abr 2026, 15:38 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Smith & Nephew PLC ADR previsión

Precio Objetivo

By TipRanks

5.52% repunte

Estimación a 12 Meses

Media 34.96 USD  5.52%

Máximo 35 USD

Mínimo 34.91 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Smith & Nephew PLC ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

2 ratings

0

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

26.64 / 28.37Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat